Shozo Nishida Selected Research

Estrogen Receptors

6/2022

EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shozo Nishida Research Topics

Disease

41	Neoplasms (Cancer) 05/2022 - 04/2002
25	Neoplasm Metastasis (Metastasis) 02/2024 - 10/2002
14	Multiple Myeloma 09/2023 - 01/2008
11	Melanoma (Melanoma, Malignant) 12/2021 - 01/2007
10	Stomach Neoplasms (Stomach Cancer) 07/2023 - 09/2012
9	Breast Neoplasms (Breast Cancer) 02/2024 - 09/2013
8	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2013 - 02/2009
6	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 06/2011
5	Carcinoma (Carcinomatosis) 03/2021 - 10/2002
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2023 - 01/2003
4	Carcinogenesis 04/2022 - 01/2007
4	Hyperalgesia 12/2020 - 05/2008
4	Osteoporosis 02/2014 - 10/2003
3	Peripheral Nervous System Diseases (PNS Diseases) 04/2023 - 06/2020
3	Brain Injuries (Brain Injury) 11/2009 - 02/2009
2	Hypoxia (Hypoxemia) 02/2023 - 01/2019
2	Hypersensitivity (Allergy) 07/2022 - 06/2011
2	Vomiting 06/2022 - 08/2013
2	Nausea 06/2022 - 08/2013
2	Squamous Cell Carcinoma of Head and Neck 03/2021 - 01/2017
2	Mucositis 01/2021 - 02/2018
2	Pain (Aches) 12/2020 - 09/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2020 - 10/2014
2	Multiple Sclerosis 09/2020 - 10/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2018 - 10/2014
2	Osteolysis 03/2016 - 01/2008
2	Metabolic Bone Diseases (Osteopenia) 02/2014 - 03/2005
2	Cognitive Dysfunction 05/2013 - 01/2013
2	Osteosarcoma (Osteogenic Sarcoma) 03/2012 - 04/2011
2	Cerebral Infarction 02/2010 - 11/2009

Drug/Important Bio-Agent (IBA)

10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2023 - 01/2008
10	Paclitaxel (Taxol)FDA LinkGeneric 05/2022 - 09/2012
10	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2007
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2023 - 06/2011
7	Antineoplastic Agents (Antineoplastics)IBA 07/2022 - 10/2003
6	SurvivinIBA 04/2023 - 10/2012
6	NF-kappa B (NF-kB)IBA 09/2020 - 10/2009
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2019 - 07/2009
5	mangiferinIBA 06/2016 - 03/2011
5	Diphosphonates (Bisphosphonates)IBA 02/2014 - 03/2005
5	Free RadicalsIBA 05/2013 - 11/2009
5	YM 529IBA 03/2012 - 01/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 12/2003
4	Dexamethasone (Maxidex)FDA LinkGeneric 09/2023 - 06/2011
4	Tamoxifen FDA LinkGeneric 06/2022 - 07/2009
4	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2013
4	Phosphotransferases (Kinase)IBA 01/2019 - 10/2004
4	Protein Kinase CIBA 10/2018 - 12/2003
4	Messenger RNA (mRNA)IBA 01/2016 - 01/2007
4	NitrogenIBA 01/2013 - 10/2010
3	Fluorouracil (Carac)FDA LinkGeneric 06/2022 - 02/2017
3	Bortezomib (Velcade)FDA Link 01/2021 - 01/2018
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2020 - 04/2011
3	Dimethyl FumarateIBA 09/2020 - 10/2009
3	Melphalan (Alkeran)FDA LinkGeneric 02/2020 - 10/2012
3	Vincristine (Oncovin)FDA LinkGeneric 10/2018 - 04/2015
3	geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA 10/2017 - 08/2011
3	CytokinesIBA 01/2017 - 12/2003
2	LigandsIBA 02/2024 - 01/2018
2	Simvastatin (Zocor)FDA LinkGeneric 04/2023 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 02/2023 - 06/2017
2	AntiemeticsIBA 06/2022 - 08/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2022 - 02/2017
2	Indicators and Reagents (Reagents)IBA 01/2021 - 07/2009
2	Imatinib Mesylate (Gleevec)FDA Link 11/2020 - 06/2017
2	Verapamil (Calan)FDA LinkGeneric 03/2020 - 01/2014
2	Dasatinib (BMS 354825)FDA Link 03/2020 - 02/2019
2	RANK LigandIBA 02/2019 - 09/2013
2	Fluvastatin FDA Link 01/2019 - 01/2008
2	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2017
2	Protein Kinases (Protein Kinase)IBA 01/2018 - 09/2010
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017 - 07/2016
2	Monoclonal AntibodiesIBA 12/2013 - 12/2012
2	Monomeric GTP-Binding ProteinsIBA 01/2013 - 10/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2012 - 07/2009
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 03/2012 - 01/2007
2	U 0126 (UO 126)IBA 03/2012 - 01/2007
2	Free Radical ScavengersIBA 02/2010 - 11/2009
2	EdaravoneIBA 02/2010 - 11/2009
2	Amyloid (Amyloid Fibrils)IBA 04/2009 - 02/2009
2	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 10/2004 - 06/2002
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2002 - 10/2002
1	Tumor Biomarkers (Tumor Markers)IBA 02/2024
1	Everolimus FDA Link 09/2023
1	Chemokine ReceptorsIBA 09/2023
1	TOR Serine-Threonine KinasesIBA 09/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023
1	JNK Mitogen-Activated Protein KinasesIBA 04/2023
1	Oxidoreductases (Dehydrogenase)IBA 04/2023
1	Coenzyme A (CoA)IBA 04/2023
1	PlatinumIBA 07/2022
1	Estrogen ReceptorsIBA 06/2022

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 07/2023 - 07/2011
21	Therapeutics 09/2023 - 03/2005
2	Chemoradiotherapy 01/2021 - 02/2018
2	Drug Tapering 12/2020 - 01/2018
2	Intravenous Administration 01/2019 - 09/2012
2	TP protocol 10/2018 - 10/2018
2	Duration of Therapy 09/2017 - 06/2011
1	Palliative Care (Palliative Therapy) 07/2023